Evidence map›Paper›PMID 38947982›Full record

ArticleContemporary clinical trials communications2024

Patients' experiences of clinical trial participation involving a product remotely assessing study drug adherence.

Catrin Henriksson, Anneli Olsson, Kasper Andersen, Gabriel Arefalk, David Erlinge, Robin Hofmann, Wilhelm Ridderstråle, Annika Rutgersson, Jonas Oldgren, Stefan James

Abstract read
In one paragraph

Article in Contemporary clinical trials communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Catrin HenrikssonCardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Anneli OlssonCardiology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Kasper AndersenCardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Gabriel ArefalkCardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
David ErlingeCardiology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Robin HofmannDivision of Cardiology, Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
Wilhelm RidderstråleLate-Stage Development, Cardiovascular, Renal and Metabolic, Biopharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden.
Annika RutgerssonDigital Health, Biopharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden.
Jonas OldgrenCardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Stefan JamesCardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The participation of patients in clinical trials is crucial for the development of healthcare. There are several challenges in the recruitment of trial participants with acute medical conditions. The registry-based randomized DAPA-MI clinical trial recruited patients during hospitalization for myocardial infarction and provided study drugs in bottles with smart caps that used wireless technology to transmit monitoring data. This interview study aimed to investigate patients' experience of participation in a clinical trial and their attitude to the new bottle cap technology. Methods: A subset of patients participating in the DAPA-MI trial were recruited from four hospitals in Sweden. Semi-structured interviews were conducted and analysed using manifest content analysis. Results: Video interviews were performed including 21 patients (four women and 17 men). The median age was 59 years (range 44-80). Four categories of patients' experiences were identified. Conclusions: Patients' experiences of trial participation were in general positive but some challenges in the acute setting of a myocardial infarction were revealed. The smart bottle cap was well accepted, despite some handling difficulties.

Indexed as

Medical technologyMyocardial infarctionPatient experienceTrial participation

Identifiers

PMID38947982
PMCPMC11214196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.